Regarding nTWIST1 negative expression, it was observed that most of these tumors presented more aggressive clinic-pathological characteristics (high proliferative activity, positive lymph node status, large tumor size, high histological grade and HER2-postive status), despite the fact that there was not a significant statistical evidence for any of these. The gene discussed is ERBB2; the disease is neoplasm.